{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:12:34Z","timestamp":1792699954372,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2019BH088"],"award-info":[{"award-number":["ZR2019BH088"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21907086"],"award-info":[{"award-number":["21907086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bmc.2025.118107","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T19:04:29Z","timestamp":1738955069000},"page":"118107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Fatty acid conjugated BimBH3 analogues with d\u2011amino acid substitution as PTPN1 inhibitors with enhanced activity, biostability and orally available potency for the treatment of diabetes"],"prefix":"10.1016","volume":"121","author":[{"given":"Liyan","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongwen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianmin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaning","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9719-0554","authenticated-orcid":false,"given":"Chuanliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118107_b0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","article-title":"Management of type 2 diabetes: new and future developments in treatment","volume":"378","author":"Tahrani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2025.118107_b0010","first-page":"838","article-title":"A review on diabetes mellitus: type1 & type2","volume":"9","author":"Kumar","year":"2020","journal-title":"World J Pharm Pharm Sci"},{"key":"10.1016\/j.bmc.2025.118107_b0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.bmc.2025.118107_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.907702","article-title":"Aqueous extract of guava (Psidium guajava L.) leaf ameliorates hyperglycemia by promoting hepatic glycogen synthesis and modulating gut microbiota","volume":"13","author":"Chu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2025.118107_b0025","article-title":"A comprehensive review of small-molecule drugs for the treatment of type 2 diabetes mellitus: synthetic approaches and clinical applications","author":"Guo","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118107_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.genrep.2024.101993","article-title":"Unraveling the molecular genetic basis of type 2 diabetes","author":"Nameghi","year":"2024","journal-title":"Gene Rep"},{"key":"10.1016\/j.bmc.2025.118107_b0035","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1186\/s12889-022-13759-9","article-title":"Prevalence, awareness and control of type 2 diabetes mellitus and risk factors in Chinese elderly population","volume":"22","author":"Yan","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bmc.2025.118107_b0040","first-page":"121","article-title":"Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders","author":"Singh","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118107_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.bmc.2025.118107_b0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/B978-0-444-53480-4.00015-1","article-title":"General aspects of diabetes mellitus","volume":"126","author":"Alam","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.bmc.2025.118107_b0055","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1021\/acs.jmedchem.2c02003","article-title":"Discovery of novel PTP1B inhibitors with once-weekly therapeutic potential for type 2 diabetes: design, synthesis, and in vitro and in vivo investigations of BimBH3 peptide analogues","volume":"66","author":"Zhang","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118107_b0060","article-title":"Synthesis and clinical application of representative small-molecule dipeptidyl peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus (T2DM)","author":"Shao","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118107_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108842","article-title":"Dipeptidyl peptidase-4 inhibition prevents vascular aging in mice under chronic stress: modulation of oxidative stress and inflammation","volume":"314","author":"Xin","year":"2019","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmc.2025.118107_b0070","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.yexcr.2011.01.010","article-title":"GLP-1 for type 2 diabetes","volume":"317","author":"Ahr\u00e9n","year":"2011","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.bmc.2025.118107_b0075","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bmc.2025.118107_b0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000497580","article-title":"Diabetes mellitus and its treatment","volume":"13","author":"Bastaki","year":"2005","journal-title":"Int J Diabet Metab"},{"key":"10.1016\/j.bmc.2025.118107_b0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/B978-0-12-407766-9.00017-1","article-title":"Protein tyrosine phosphatase 1B (PTP1B) and obesity","volume":"91","author":"Cho","year":"2013","journal-title":"Vitam Horm"},{"key":"10.1016\/j.bmc.2025.118107_b0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1517\/13543784.12.2.223","article-title":"PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity","volume":"12","author":"Zhang","year":"2003","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.bmc.2025.118107_b0095","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41574-024-00965-1","article-title":"Protein tyrosine phosphatase 1B in metabolic diseases and drug development","volume":"20","author":"Delibegovi\u0107","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.bmc.2025.118107_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112376","article-title":"Recent advance on PTP1B inhibitors and their biomedical applications","volume":"199","author":"Sharma","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118107_b0105","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41574-024-00965-1","article-title":"Protein tyrosine phosphatase 1B in metabolic diseases and drug development","volume":"20","author":"Delibegovi\u0107","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.bmc.2025.118107_b0110","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1021\/acs.jmedchem.4c00356","article-title":"Discovery of selective proteolysis-targeting chimera degraders targeting PTP1B as long-term hypoglycemic agents","volume":"67","author":"Yang","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118107_b0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.drudis.2007.03.011","article-title":"PTP1B as a drug target: recent developments in PTP1B inhibitor discovery","volume":"12","author":"Zhang","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2025.118107_b0120","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.beem.2007.08.004","article-title":"Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus","volume":"21","author":"Koren","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.bmc.2025.118107_b0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2015.12.025","article-title":"TC-PTP and PTP1B: regulating JAK\u2013STAT signaling, controlling lymphoid malignancies","volume":"82","author":"Pike","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.bmc.2025.118107_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113978","article-title":"Peptide mediated therapy in fibrosis: mechanisms, advances and prospects","volume":"157","author":"Ye","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2025.118107_b0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","article-title":"Trends in peptide drug discovery","volume":"20","author":"Muttenthaler","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2025.118107_b0140","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/acs.jmedchem.7b00318","article-title":"The current state of peptide drug discovery: back to the future?","volume":"61","author":"Henninot","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118107_b0145","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cbdd.12055","article-title":"The future of peptide-based drugs","volume":"81","author":"Craik","year":"2013","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2025.118107_b0150","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40259-015-0133-6","article-title":"Fusion proteins for half-life extension of biologics as a strategy to make biobetters","volume":"29","author":"Strohl","year":"2015","journal-title":"BioDrugs"},{"key":"10.1016\/j.bmc.2025.118107_b0155","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41573-019-0053-0","article-title":"Advances in oral peptide therapeutics","volume":"19","author":"Drucker","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2025.118107_b0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00063030-200519030-00003","article-title":"Oral delivery of peptide drugs","volume":"19","author":"Hamman","year":"2005","journal-title":"BioDrugs"},{"key":"10.1016\/j.bmc.2025.118107_b0165","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.2174\/138161210793292555","article-title":"Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization","volume":"16","author":"Gentilucci","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmc.2025.118107_b0170","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/dom.14603","article-title":"Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: a systematic literature review","volume":"24","author":"Evans","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bmc.2025.118107_b0175","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.bmc.2017.09.016","article-title":"Prospects of PASylation\u00ae for the design of protein and peptide therapeutics with extended half-life and enhanced action","volume":"26","author":"Gebauer","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118107_b0180","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2025.118107_b0185","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.bmc.2018.01.012","article-title":"Peptide chemistry toolbox\u2013transforming natural peptides into peptide therapeutics","volume":"26","author":"Erak","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118107_b0190","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00726-023-03245-w","article-title":"Rational design of stapled antimicrobial peptides","volume":"55","author":"You","year":"2023","journal-title":"Amino Acids"},{"key":"10.1016\/j.bmc.2025.118107_b0195","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0196-9781(01)00537-X","article-title":"Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability","volume":"22","author":"Witt","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.bmc.2025.118107_b0200","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2025.118107_b0205","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.2017.14752","article-title":"Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes: a randomized clinical trial","volume":"318","author":"Davies","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.bmc.2025.118107_b0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41573-022-00529-w","article-title":"Derivatization with fatty acids in peptide and protein drug discovery","volume":"22","author":"Kurtzhals","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2025.118107_b0215","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00726-017-2459-5","article-title":"An overview on d-amino acids","volume":"49","author":"Genchi","year":"2017","journal-title":"Amino Acids"},{"key":"10.1016\/j.bmc.2025.118107_b0220","doi-asserted-by":"crossref","DOI":"10.3390\/biom11111716","article-title":"D-amino acids and D-amino acid-containing peptides: potential disease biomarkers and therapeutic targets?","volume":"11","author":"Abdulbagi","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bmc.2025.118107_b0225","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1046\/j.1464-410X.2003.04308.x","article-title":"Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer","volume":"92","author":"Heyns","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.bmc.2025.118107_b0230","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/protein\/gzu037","article-title":"Nature versus design: the conformational propensities of D-amino acids and the importance of side chain chirality","volume":"27","author":"Towse","year":"2014","journal-title":"Protein Eng Des Sel"},{"key":"10.1016\/j.bmc.2025.118107_b0235","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/acsmedchemlett.1c00174","article-title":"Discovery of novel PTP1B inhibitors derived from the BH3 domain of proapoptotic Bcl-2 proteins with antidiabetic potency","volume":"12","author":"Zhang","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118107_b0240","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1021\/acsptsci.4c00054","article-title":"Site-specifically modified peptide inhibitors of protein tyrosine phosphatase 1B and T-cell protein tyrosine phosphatase with enhanced stability and improved in vivo long-acting activity","volume":"7","author":"Zhang","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.bmc.2025.118107_b0245","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bmcl.2018.11.047","article-title":"BH3 mimetics derived from Bim-BH3 domain core region show PTP1B inhibitory activity","volume":"29","author":"Lu","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118107_b0250","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2174\/1389557520666200628032507","article-title":"The research progress of DPP-4 inhibitors","volume":"20","author":"Sun","year":"2020","journal-title":"Mini-Rev Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625000483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625000483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:27:24Z","timestamp":1777602444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625000483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":50,"alternative-id":["S0968089625000483"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118107","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatty acid conjugated BimBH3 analogues with d\u2011amino acid substitution as PTPN1 inhibitors with enhanced activity, biostability and orally available potency for the treatment of diabetes","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118107"}}